
The acquisition of regenerative medicine firm LifeCell by Allergan for $2.9 billion announced back in December has been completely successfully, …

Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

